Business
SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025
SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINA...
About this update from Simply Solventless Concentrates Ltd
[{"type":"text","content":"\n\n\n\n SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025\n \n\n Canada NewsWire\n \n\n\n\n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN\n \n THE UNITED STATES\n \n ./\n \n\n\n\n CALGARY, AB\n \n\n ,\n \n\n Feb. 3, 2025\n \n\n /CNW/ - Simply Solventless Concentrates Ltd. (TSXV: HASH) (\"\n \n SSC\n \n \") is pleased to announce that due to very strong demand it intends to over subscribe the previously announced non-brokered secured convertible debenture unit (\"\n \n Debenture Unit\n \n \") financing from\n \n $5.0 million\n \n to\n \n $6.0 million\n \n (the \"\n \n Offering\n \n \") (\n \n see Debenture Unit financing announcement\n \n ).\n \n $375,000\n \n of the Offering is being subscribed by insiders.  SSC is pleased to also announce that it has received approval from the Court of King's Bench of\n \n Alberta\n \n pursuant to Delta 9 Cannabis Inc.'s proceedings under the Companies' Creditors Arrangement Act, to complete the acquisition of Delta 9 Bio-Tech (\"\n \n Bio-Tech\n \n \") as previously announced on\n \n December 30, 2024\n \n (\n \n see Bio-Tech acquisition announcement\n \n ).  SSC anticipates closing the strategic acquisition of Bio-Tech on or about\n \n February 7, 2025\n \n .\n \n\n\n\n\n\n\n\n\n\n Jeff Swainson\n \n , SSC President & CEO stated: \"To date, SSC has received approximately\n \n $8.0 million\n \n of indicative demand for the Offering. We would like to thank all participants for their confidence in SSC. While we are not over subscribing to the full extent of the indicative demand, the over subscription to\n \n $6.0 million\n \n provides a distinct advantage.\" Swainson elaborated: \"SSC has an acquisit...